Furthermore, BMP is the predominant pathway affected by known common predisposition variants in CRC.73,75–77 Upregulation of SMAD1 is seen in p53 mutated tumours acting to stabilise p53 and suppresses oncogenesis.78 This evidence concerns the gene TP53 and neoplasm.